EU panel recommends against PTC muscular disorder drug

PTC Therapeutics Inc said a committee of the European Medicines Agency recommended against a conditional approval to its drug for the treatment of a rare muscular disorder, sending its shares down nearly 30 percent in premarket trading.

http://ift.tt/1g8m3iU